StonvexLoading…
StonvexStonvexStonvexCore line items from TMCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $212.69M | $209.36M | $187.12M | $141.84M |
Operating Income | $-54.15M | $-55.69M | $-51.43M | $-34.84M |
Net Income | $-59.00M | $-55.74M | $-49.53M | $-42.81M |
EPS (Diluted) | $-0.93 | $-0.90 | $-0.81 | $-0.77 |
Total Assets | $190.58M | $217.09M | $251.91M | $159.02M |
Total Liabilities | $103.25M | $104.20M | $113.97M | $98.50M |
Cash & Equivalents | $10.71M | $11.35M | $12.98M | $19.47M |
Free Cash Flow OCF − CapEx | $-29.49M | $-48.76M | $-46.03M | $-45.49M |
Shares Outstanding | 63.27M | 62.11M | 61.75M | 55.63M |